Global Market Bulletin
  • Home
  • Stock Market News
  • Investing
  • Economy
  • CEO Interviews
  • Contact Us
No Result
View All Result
SUBSCRIBE
Global Market Bulletin
  • Home
  • Stock Market News
  • Investing
  • Economy
  • CEO Interviews
  • Contact Us
No Result
View All Result
Global Market Bulletin
No Result
View All Result
Home Stock Market News

10 Stocks Under $10 Analysts Believe Could Soar 200%

by Global Market Bulletin
July 18, 2026
in Stock Market News
0
10 Stocks Under $10 Analysts Believe Could Soar 200%

10 Stocks Under $10 Analysts Believe Could Soar 200%

40
SHARES
86
VIEWS
Share on FacebookShare on Twitter

9. Sable Offshore Corp. (NYSE:SOC)

Sable Offshore Corp. (NYSE: SOC) ranks ninth among the best stocks under $10 that could triple, with shares recently priced at approximately $4.35 following a 5.07% increase. Unlike the biotechnology-heavy names in this countdown, Sable Offshore Corp. (NYSE: SOC) offers investors exposure to the oil and gas industry, including offshore production assets and supporting pipeline infrastructure.

You might also like

Is Omeros (OMER) a Smart Biotech Investment Before Its Next Major Catalyst?

Is AtaiBeckley (ATAI) a Smart Psychedelic Medicine Stock to Buy Now?

Is SAB Biotherapeutics (SABS) an Undervalued Biotech Stock Ready to Take Off?

On July 6, Jefferies analyst Lloyd Byrne reduced the price target for Sable Offshore Corp. (NYSE: SOC) from $24 to $11. The cut was substantial and reflected the serious challenges surrounding the company’s current situation. However, even after the price target was lowered by more than half, the revised $11 estimate still suggested upside of more than 180% from the referenced share price.

Jefferies maintained its Buy rating on Sable Offshore Corp. (NYSE: SOC), indicating that the analyst continued to see meaningful recovery potential despite financing pressure, regulatory uncertainty, and dilution concerns. This is an important distinction. The analyst did not dismiss the company’s difficulties, but instead concluded that the remaining value of its assets and potential operations could still justify a significantly higher valuation than the market was assigning to the stock.

One of the central concerns is dilution. Sable Offshore Corp. (NYSE: SOC) recently raised capital through a combination of common shares and convertible senior notes. While such transactions can provide a company with necessary funding, they can also reduce the proportional ownership of existing shareholders. Convertible notes create additional potential dilution because the debt can eventually be converted into common stock under specified conditions.

The financing was completed after the company failed to secure the government support it had been seeking. For an energy company operating offshore infrastructure and production assets, government approvals and regulatory cooperation can be critical. Delays or unfavorable decisions can affect operating timelines, cash flow expectations, financing requirements, and investor confidence.

On July 1, Sable Offshore Corp. (NYSE: SOC) disclosed additional information regarding its public offerings. The company offered 32,467,533 common shares at $3.08 per share. It also issued 6.5% convertible senior notes with a total principal amount of $300 million, scheduled to mature in 2031.

The company granted underwriters a 30-day option to purchase up to an additional 4,870,129 common shares and as much as $45 million in additional convertible notes to cover over-allotments. Should those options be fully exercised, the company would receive additional capital, but existing shareholders could experience further dilution.

The convertible notes are senior unsecured obligations that will accrue interest at an annual rate of 6.5%, payable twice a year. Because the notes are unsecured, they are not directly backed by specific company assets. However, they still rank as senior obligations in the company’s capital structure, meaning noteholders would generally have a higher claim than common shareholders if the company were to face financial distress.

The initial conversion rate was established at 249.7502 shares for every $1,000 principal amount of notes. This corresponds to an estimated conversion price of approximately $4 per share, representing a premium of around 30% compared with the common-share offering price.

The structure gives noteholders an opportunity to benefit if the company’s stock rises above the conversion level. For ordinary shareholders, however, it creates the possibility that a large amount of debt could eventually become equity, expanding the share count and limiting the upside available per share.

This is why the investment thesis for Sable Offshore Corp. (NYSE: SOC) is not a simple story about buying an inexpensive oil stock. It is a high-risk turnaround and execution story. The company must navigate regulatory issues, restore or expand production, control financing costs, manage its balance sheet, and demonstrate that its offshore assets can generate sufficient long-term economic value.

Sable Offshore Corp. (NYSE: SOC) operates as an independent oil and gas production company involved in exploration, production, and marketing. The company also operates a subsea pipeline system that transports crude oil, natural gas, and produced water from offshore locations to processing facilities.

Pipeline infrastructure can provide strategic value because it connects offshore production assets with onshore processing operations. However, that infrastructure also requires maintenance, regulatory compliance, environmental safeguards, and significant capital investment. Offshore energy projects can be highly profitable when production volumes are strong and oil prices are favorable, but they can also become financially burdensome when operations are delayed.

For investors searching for energy stocks under $10, oil stocks with high upside, or speculative small-cap stocks that could triple, Sable Offshore Corp. (NYSE: SOC) presents an unusual setup. The upside could be substantial if the company resolves its regulatory challenges and successfully brings its assets into productive operation. At the same time, the risks associated with dilution, debt, government approvals, operating delays, and energy-price volatility remain impossible to overlook.

The Jefferies price target suggests that Wall Street still sees considerable value in the company. But this is one case where investors should pay as much attention to the company’s capital structure and regulatory progress as they do to the headline upside percentage.

Click next to see the following stock...

Page 2 of 5
Prev123...5Next
Tags: 10 Stocks Under $10 Analysts Believe Could Soar 200%AtaiBeckley N.V. (NASDAQ:ATAI)Daily NewsletterHeadlineLarimar Therapeutics Inc. (NASDAQ:LRMR)NASDAQ:ATAINASDAQ:LRMRNASDAQ:SABSNASDAQ:VSTMNYSE:SOCSAB Biotherapeutics Inc. (NASDAQ:SABS)Sable Offshore Corp. (NYSE:SOC)Verastem Inc. (NASDAQ:VSTM)Yahoo Finance
Share16Tweet10

Global Market Bulletin

Global Market Bulletin is a leading provider of stock market updates, economic news, and personalized investing guides. Our team brings you the latest global financial information to help you make smart investment decisions. About the Editorial Team Our editorial team consists of financial experts and seasoned market analysts who bring decades of experience to our coverage. With a commitment to unbiased reporting, our team ensures that every article is backed by thorough research and delivers accurate financial insights.

Recommended For You

Is Omeros (OMER) a Smart Biotech Investment Before Its Next Major Catalyst?

by Global Market Bulletin
July 18, 2026
0
Is Omeros (OMER) a Smart Biotech Investment Before Its Next Major Catalyst?

We recently published our article 5 Stocks Under $10 Analysts Believe Could Soar 200%. To read the full story, you can go directly to 10 Stocks Under $10...

Read moreDetails

Is AtaiBeckley (ATAI) a Smart Psychedelic Medicine Stock to Buy Now?

by Global Market Bulletin
July 18, 2026
0
Is AtaiBeckley (ATAI) a Smart Psychedelic Medicine Stock to Buy Now?

We recently published our article 10 Stocks Under $10 Analysts Believe Could Soar 200%. In this article, we discuss AtaiBeckley N.V. (NASDAQ:ATAI) as one of the stocks gaining attention,...

Read moreDetails

Is SAB Biotherapeutics (SABS) an Undervalued Biotech Stock Ready to Take Off?

by Global Market Bulletin
July 18, 2026
0
Is Omeros (OMER) a Smart Biotech Investment Before Its Next Major Catalyst?

We recently published our article 10 Stocks Under $10 Analysts Believe Could Soar 200%. In this article, we discuss SAB Biotherapeutics Inc. (NASDAQ:SABS) as one of the stocks gaining...

Read moreDetails

What Makes Larimar Therapeutics (LRMR) a Potential Rare-Disease Breakout Stock?

by Global Market Bulletin
July 18, 2026
0
What Makes Larimar Therapeutics (LRMR) a Potential Rare-Disease Breakout Stock?

We recently published our article 10 Stocks Under $10 Analysts Believe Could Soar 200%. In this article, we discuss Larimar Therapeutics Inc. (NASDAQ:LRMR) as one of the stocks gaining...

Read moreDetails

Is Sable Offshore (SOC) a Good Energy Stock to Buy Right Now?

by Global Market Bulletin
July 18, 2026
0
Is Sable Offshore (SOC) a Good Energy Stock to Buy Right Now?

We recently published our article 10 Stocks Under $10 Analysts Believe Could Soar 200%. In this article, we discuss Sable Offshore Corp. (NYSE:SOC) as one of the stocks gaining...

Read moreDetails

Browse by Category

  • CEO Interviews
  • Economy
  • Investing
  • Stock Market News
  • Uncategorized

QUICK LINKS

  • Stock Market News
  • Investing
  • Economy
  • Contact Us
  • About Global Market Bulletin
  • Editorial Policy – Global Market Bulletin
  • Our Editorial Team

RECENT POSTS

  • Is Omeros (OMER) a Smart Biotech Investment Before Its Next Major Catalyst?
  • Is AtaiBeckley (ATAI) a Smart Psychedelic Medicine Stock to Buy Now?
  • Is SAB Biotherapeutics (SABS) an Undervalued Biotech Stock Ready to Take Off?

GET EMAIL MARKET UPDATES

Subscribe to our mailing list to receives daily updates direct to your inbox!
  • Privacy Policy
  • Terms and Conditions

© 2022 Global Market Bulletin. All Rights Reserved.

No Result
View All Result
  • Home
  • Stock Market News
  • Investing
  • Economy

© 2022 Global Market Bulletin. All Rights Reserved.

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?